Matches in Wikidata for { <http://www.wikidata.org/entity/Q94318234> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q94318234 description "article scientifique publié en 2019" @default.
- Q94318234 description "wetenschappelijk artikel" @default.
- Q94318234 description "наукова стаття" @default.
- Q94318234 name "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 name "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 type Item @default.
- Q94318234 label "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 label "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 prefLabel "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 prefLabel "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 P1433 Q94318234-0C714752-813F-4537-AFAE-2CB734173753 @default.
- Q94318234 P1476 Q94318234-4FD38090-E4B6-43EB-999A-AC3F3E0E78EC @default.
- Q94318234 P2093 Q94318234-09A69893-DB1A-40DD-995A-CC08452F95B9 @default.
- Q94318234 P2093 Q94318234-5971364C-1CAD-49A4-B8B6-53EE3770AC98 @default.
- Q94318234 P2093 Q94318234-6075F38C-0607-4E95-907B-F2033759DA9D @default.
- Q94318234 P2093 Q94318234-C963D1A0-4DF3-486F-AFDB-076E1FAAB182 @default.
- Q94318234 P304 Q94318234-A54C76E4-7324-4335-ADD9-F2CD662AE88F @default.
- Q94318234 P31 Q94318234-0803D068-5FFB-4D7E-B780-A58BDA5EE690 @default.
- Q94318234 P356 Q94318234-7987C229-7A19-4B7F-93C6-5395EE8067A5 @default.
- Q94318234 P433 Q94318234-E6F9BEA2-62AC-48B0-82AA-1C5E1B1AAFEE @default.
- Q94318234 P478 Q94318234-C1FFFF6F-3A90-4226-A95A-3A84D6A47274 @default.
- Q94318234 P577 Q94318234-CDE583C8-4F12-4F76-85B5-E12EF0871311 @default.
- Q94318234 P921 Q94318234-A79B83B9-00C9-4C82-A7DC-2E7AD430C313 @default.
- Q94318234 P932 Q94318234-23BC991F-615B-4C7C-A398-01BEB36E9405 @default.
- Q94318234 P356 SBZ018.525 @default.
- Q94318234 P1433 Q4049133 @default.
- Q94318234 P1476 "F113. LONG-TERM PHYSICAL HEALTH AND MORTALITY OUTCOMES OF PATIENTS WITH SCHIZOPHRENIA WITH CLOZAPINE AUGMENTATION WITH ANTI-PSYCHOTIC DRUGS" @default.
- Q94318234 P2093 "Amir Krivoy" @default.
- Q94318234 P2093 "Michal Taler" @default.
- Q94318234 P2093 "Moshe Hoshen" @default.
- Q94318234 P2093 "Weizman Abraham" @default.
- Q94318234 P304 "S297-S297" @default.
- Q94318234 P31 Q13442814 @default.
- Q94318234 P356 "10.1093/SCHBUL/SBZ018.525" @default.
- Q94318234 P433 "Suppl 2" @default.
- Q94318234 P478 "45" @default.
- Q94318234 P577 "2019-04-09T00:00:00Z" @default.
- Q94318234 P921 Q41112 @default.
- Q94318234 P932 "6455357" @default.